Sarah B. Fisher, Sameer H. Patel, Pelin Bagci, David A. Kooby, Bassel F. El-Rayes, Charles A. Staley III, N. Volkan Adsay and Shishir K. Maithel An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma Cancer 119
Article first published online: 8 MAY 2012 | DOI: 10.1002/cncr.27619
High tumor expression of either ribonucleoside reductase subunit M2 or excision repair cross-complementing gene-1 is associated with reduced recurrence-free survival and overall survival after resection of pancreas adenocarcinoma. These biomarkers may help to personalize adjuvant therapy.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.